Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

22 Nov 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Clementia Pharmaceuticals qtrly loss per share ‍$1.83​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Clementia Pharmaceuticals Inc ::Clementia Pharmaceuticals Inc - qtrly loss per share ‍$1.83​.Clementia Pharmaceuticals Inc- ‍as of September 30, 2017, had cash and investments of $152.2 million​.Clementia - ‍anticipates reporting preliminary results from part b open-label extension portion of phase ii study of palovarotene in fop in Q2 2018​.Clementia Pharmaceuticals Inc- on track to begin move study protocol phase iii study and enroll first patient by end of 2017​.  Full Article